CAH

Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as it owns urology MSO. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.

Wall Street analysts forecast CAH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CAH is 213.91 USD with a low forecast of 187.00 USD and a high forecast of 232.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Cardinal Health Inc revenue for the last quarter amounts to 64.01B USD, increased 22.44 % YoY.

Cardinal Health Inc. EPS for the last quarter amounts to 1.88 USD, increased 10.59 % YoY.

Cardinal Health Inc (CAH) has 57700 emplpoyees as of January 09 2026.

Today CAH has the market capitalization of 48.11B USD.